Whitehawk Therapeutics Inc (NASDAQ: WHWK) Added 3.54 Percent In The Last Seven Days: What Lifted The Stock?

Whitehawk Therapeutics Inc (NASDAQ:WHWK)’s traded shares stood at 0.4 million during the last session, with the company’s beta value hitting 0.70. At the close of trading, the stock’s price was $2.05, to imply an increase of 4.59% or $0.09 in intraday trading. The WHWK share’s 52-week high remains $3.81, putting it -85.85% down since that peak but still an impressive 40.98% since price per share fell to its 52-week low of $1.21. The company has a valuation of $50.63M, with an average of 0.24 million shares in intraday trading volume over the past 10 days and average of 219.98K shares over the past 3 months.

Whitehawk Therapeutics Inc (NASDAQ:WHWK) trade information

After registering a 4.59% upside in the last session, Whitehawk Therapeutics Inc (WHWK) has traded red over the past five days. The 5-day price performance for the stock is 3.54%, and -28.32% over 30 days. With these gigs, the year-to-date price performance is -35.02%.

An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 22.81% for the past 5-year period. While 2025 is set for a 71.82% return in earnings, projections for the next 5 years are at 22.70% annually.

WHWK Dividends

Whitehawk Therapeutics Inc has its next earnings report out on 2025-Mar-17. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.

We also have Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund as the top two Mutual Funds with the largest holdings of the Whitehawk Therapeutics Inc (WHWK) shares. Going by data provided on Dec 31, 2024 , Vanguard Total Stock Market Index Fund holds roughly 499.93 shares. This is just over 2.02% of the total shares, with a market valuation of $1.02 million. Data from the same date shows that the other fund manager holds a little less at 247.52, or 1.00% of the shares, all valued at about 0.51 million.